What's NEW in Bioanalytical Testing? What does the change in FDA guidelines mean for your company?

Join Invitrox for a discussion on the 2018 changes to the FDA guidelines for analytical testing and enjoy mingling and networking with fellow scientists over drinks and light hors d'hoeurves.

The Invitrox team has extensive experience solving bioanalytical and analytical issues from all stages of preclinical and clinical pharmaceutical development.

Invitrox offers custom packages for:

• Method development
• GLP validation
• Pre-clinical and clinical bioanalysis
• High-throughput in vitro assay screening
• Transporter interactions
• Particle Sizing Analysis:
• Determine presence and extent of particle aggregation
• Use high resolution fingerprints of particle size to track stability
• Quantify rates of reactions for visible reactants